To date, PRSs have appeared to strengthen AD diagnostic classification beyond the use of APOE, as PRSs can discriminate AD cases from controls, with a prediction accuracy of approximately 70–80% [13]. The gene discussed is APOE; the disease is Alzheimer disease.